Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00244894 · ClinicalTrials.gov registry record · NA
Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer
A NA study, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT00244894: Clinical Trial NA study, sponsored by OHSU Knight Cancer Institute.
NCT00244894 is a NA study that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00244894, a NA study, was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
RATIONALE: Acupuncture may help relieve hot flashes in patients with prostate cancer. PURPOSE: This clinical trial is studying how well acupuncture works in treating hot flashes in patients with prostate cancer who are undergoing androgen deprivation.
Interventions
- PROCEDURE quality-of-life assessment
- PROCEDURE management of therapy complications
- PROCEDURE acupuncture therapy
- PROCEDURE fatigue assessment and management
- PROCEDURE hot flashes attenuation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2002-09 |
| Est. Completion | 2010-04 |
| Phase | NA |
Why NCT00244894 stopped before completion
NCT00244894 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 5 interventions - of which quality-of-life assessment is the first listed.
NCT00244894 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00244894 about?
NCT00244894 is a clinical study titled "Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer". RATIONALE: Acupuncture may help relieve hot flashes in patients with prostate cancer. PURPOSE: This clinical trial is studying how well acupuncture works in treating hot flashes in patients with prostate cancer who are undergoing androgen deprivation.
What is the current status of trial NCT00244894?
This trial is currently terminated. It is a NA study. The enrollment target is 22 participants. The study started on 2002-09. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00244894?
The interventions under investigation include: quality-of-life assessment (PROCEDURE), management of therapy complications (PROCEDURE), acupuncture therapy (PROCEDURE), fatigue assessment and management (PROCEDURE), hot flashes attenuation (PROCEDURE).
Who is sponsoring clinical trial NCT00244894?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00244894's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia